According to Insulet's latest financial reports the company's current earnings (TTM) are $0.24 B. an increase over its 2022 earnings that were of $43.1 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $0.24 B | 476.57% |
2022 | $43.1 M | -45.24% |
2021 | $78.7 M | 43.35% |
2020 | $54.9 M | 18.51% |
2019 | $46.32 M | 41.16% |
2018 | $32.81 M | -711.95% |
2017 | -$5.37 M | -56.85% |
2016 | -$12.43 M | -79.31% |
2015 | -$60.09 M | 63.85% |
2014 | -$36.68 M | 31.04% |
2013 | -$27.99 M | -21.96% |
2012 | -$35.87 M | |
2010 | -$34.21 M | -42.38% |
2009 | -$59.36 M | -33.56% |
2008 | -$89.35 M | 65.93% |
2007 | -$53.85 M | 209.75% |
2006 | -$17.39 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | 6,729.78% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $6.66 B | 2,581.69% | ๐บ๐ธ USA |
Medtronic MDT | $6.23 B | 2,409.05% | ๐ฎ๐ช Ireland |
Eli Lilly LLY | $6.55 B | 2,537.67% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | -$0.23 B | -188.63% | ๐บ๐ธ USA |
ICU Medical
ICUI | $24.42 M | -90.17% | ๐บ๐ธ USA |
DexCom DXCM | $0.73 B | 194.04% | ๐บ๐ธ USA |